Loans (Details) ₪ / shares in Units, $ / shares in Units, $ in Thousands, ₪ in Millions |
1 Months Ended | 3 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 09, 2020
USD ($)
|
Dec. 09, 2020
ILS (₪)
|
Jul. 01, 2020
USD ($)
|
Nov. 30, 2021
USD ($)
|
Jan. 31, 2021
USD ($)
|
Mar. 31, 2023
USD ($)
$ / shares
|
Mar. 31, 2023
₪ / shares
|
Dec. 31, 2020
USD ($)
|
|
| Loans [Abstract] | ||||||||
| Fund received | $ 150 | |||||||
| Bear interest, percentage | 3.75% | 9.60% | 9.60% | |||||
| New loan | $ 6,000 | ₪ 20 | ||||||
| Received loan | $ 3,000 | |||||||
| Additional loan | $ 2,000 | |||||||
| New lender warrants | $ 1,500 | |||||||
| Additional funding amount of new lender | $ 1,000 | |||||||
| Increased value of new lender warrant | 1,800 | |||||||
| Loan balance outstanding | 4,758 | |||||||
| Current maturities | 1,198 | |||||||
| loan agreement value | 2,000 | |||||||
| Additional loan covenants | $ 2,000 | |||||||
| Exchange rate | (per share) | $ 1 | ₪ 3.615 | ||||||
| X | ||||||||||
- Definition The Amount of additional for loan origination associated cost which is usually collected through escrow. No definition available.
|
| X | ||||||||||
- Definition Adjustment for noncash service expenses paid for by granting of warrants. No definition available.
|
| X | ||||||||||
- Definition Exchange rate translation. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The Amount for loan origination associated cost which is usually collected through escrow. No definition available.
|
| X | ||||||||||
- Definition loan agreement value. No definition available.
|
| X | ||||||||||
- Definition Amount of regulatory assistance received from a federal regulatory agency in conjunction with either an acquisition of a troubled financial institution, transfer of nonperforming assets to a newly-formed entity, or other reorganization. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The undiscounted sum of all amounts, including amounts deemed principal, interest, fees, penalties, and other under the loan, owed to the investor at the reporting date, whether or not currently due and whether or not any such amounts have been written or charged off by the investor. This relates to loans accounted for as debt securities, with evidence of deterioration of credit quality since origination that were acquired by completion of a transfer for which it is probable, at acquisition, that the investor will be unable to collect all contractually required payments receivable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of undisbursed portion of financing receivable balance. Excludes financing receivable covered under loss sharing agreement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase in fund from payment received from affiliate to reimburse fund for loss on investment transaction and increase (decrease) from gain (loss) on investment not meeting investment guideline of fund. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of long-term debt and lease obligation, including portion classified as current. No definition available.
|
| X | ||||||||||
- Definition The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in equity for down round feature triggered for warrant classified as equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|